Bond Screener
Amgen
LEI 62QBXGPJ34PQ72Z12S66, SWIFT AGGNUS62XXX
Organization name
Amgen, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
60,442 mln USD
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
|
General information
-
Organization nameAmgen, Inc.
-
Organization statusOperating organization
-
AddressC/O Corporation Service Company 2711 Centerville Road Suite 400 Wilmington, USA, 19808
-
Site
-
IR Site
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameAmgen, Inc.
-
Organization statusOperating organization
-
AddressC/O Corporation Service Company 2711 Centerville Road Suite 400 Wilmington, USA, 19808
-
Site
-
IR Site
Codes
-
LEI62QBXGPJ34PQ72Z12S66
-
SWIFTAGGNUS62XXX
-
SIC2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0000318154
-
EIN95-3540776
